HowardJengHuangMD
Pulmonology • Houston, TXCritical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine, Pleural Disease
Chief, Section of Lung Transplantation, Houston Methodist Hospital
Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6550 Fannin St
Ste 1101
Houston, TX 77030Phone+1 713-441-2215Fax+1 713-791-5043
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2008
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Texas Southwestern Medical SchoolClass of 2000
Certifications & Licensure
MO State Medical License 2004 - 2026
TX State Medical License 2003 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Research Fellowship Award International Society for Heart and Lung Transplantation
- Phillip K. Caves Award International Society for Heart and Lung Transplantation
Publications & Presentations
PubMed
- Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation.Hrishikesh S Kulkarni, Laneshia K Tague, Daniel R Calabrese, Fuyi Liao, Zhiyi Liu
Biorxiv. 2024-11-18 - Enhanced recovery after surgery may mitigate the risks associated with robotic-assisted fundoplication in lung transplant patients.Rebecca Wu, Valeria Robayo, Duc T Nguyen, Edward Y Chan, Ray Chihara
Surgical Endoscopy. 2024-04-01 - 4 citationsA Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation.Howard J Huang, Kenneth Schechtman, Medhat Askar, Cory Bernadt, Brigitte Mitter
Transplantation. 2024-03-01
Press Mentions
Basal Stem Cell Variant May Be Therapeutic Target in IPF, Study FindsMay 23rd, 2023- Variant Cells Discovered in Lungs of Individuals with Idiopathic Pulmonary Fibrosis, as Per the Analysis by Science NewsMay 18th, 2023
- Odd Cells Found in Lungs of Patients with Idiopathic Pulmonary FibrosisMay 17th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
